Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard West

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Translational Lung Cancer Research|March 26, 2015
Nivolumab as first line monotherapy for advanced non-small cell lung cancer: could we replace first line chemotherapy with immunotherapy?Howard West
Clinics in Chest Medicine|May 14, 2020
Management of Oligometastatic Disease in Advanced Non-Small Cell Lung CancerHoward West
Annals of Translational Medicine|October 24, 2017
Prioritizing molecular markers to test for in the initial workup of advanced non-small cell lung cancer: wants versus needsHoward West
JAMA Network Open|July 7, 2022
Current and Future Questions for Telemedicine Research in Oncology-Moving Beyond FeasibilityHoward West
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable valueHoward West
Translational Lung Cancer Research|February 11, 2021
Prognostic models for immunotherapy: emerging factors for an evolving treatment landscapeHoward West
Current Treatment Options in Oncology|December 14, 2005
Emerging approaches to advanced bronchioloalveolar carcinomaHoward West
Journal of Thoracic Disease|April 30, 2015
Individualizing adjuvant therapy for early stage non-small cell lung cancer: we see the destination, but we don't yet know the routeHoward West
Current Oncology Reports|June 3, 2011
The evolving role of targeted therapy in early-stage and locally advanced non-small cell lung cancerHoward West
JAMA Oncology|May 20, 2016
Lymph Nodes and Lymphadenopathy in CancerHoward West, Jill Jin
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Translational Lung Cancer Research|March 26, 2015
Nivolumab as first line monotherapy for advanced non-small cell lung cancer: could we replace first line chemotherapy with immunotherapy?Howard West
Clinics in Chest Medicine|May 14, 2020
Management of Oligometastatic Disease in Advanced Non-Small Cell Lung CancerHoward West
Annals of Translational Medicine|October 24, 2017
Prioritizing molecular markers to test for in the initial workup of advanced non-small cell lung cancer: wants versus needsHoward West
JAMA Network Open|July 7, 2022
Current and Future Questions for Telemedicine Research in Oncology-Moving Beyond FeasibilityHoward West
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable valueHoward West
Translational Lung Cancer Research|February 11, 2021
Prognostic models for immunotherapy: emerging factors for an evolving treatment landscapeHoward West
Current Treatment Options in Oncology|December 14, 2005
Emerging approaches to advanced bronchioloalveolar carcinomaHoward West
Journal of Thoracic Disease|April 30, 2015
Individualizing adjuvant therapy for early stage non-small cell lung cancer: we see the destination, but we don't yet know the routeHoward West
Current Oncology Reports|June 3, 2011
The evolving role of targeted therapy in early-stage and locally advanced non-small cell lung cancerHoward West
JAMA Oncology|May 20, 2016
Lymph Nodes and Lymphadenopathy in CancerHoward West, Jill Jin
Pageof 5